245 related articles for article (PubMed ID: 31183988)
1. Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery.
Wharton S; Kuk JL; Luszczynski M; Kamran E; Christensen RAG
Clin Obes; 2019 Aug; 9(4):e12323. PubMed ID: 31183988
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery.
Muratori F; Vignati F; Di Sacco G; Gavazzi L; Pellegrino D; Del Prete M
Eat Weight Disord; 2022 Oct; 27(7):2775-2781. PubMed ID: 35763245
[TBL] [Abstract][Full Text] [Related]
3. Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Angelidi AM; Kokkinos A; Sanoudou D; Connelly MA; Alexandrou A; Mingrone G; Mantzoros CS
Metabolism; 2023 Jan; 138():155346. PubMed ID: 36375643
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery.
Rye P; Modi R; Cawsey S; Sharma AM
Obes Surg; 2018 Nov; 28(11):3553-3558. PubMed ID: 30022424
[TBL] [Abstract][Full Text] [Related]
5. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study.
Stanford FC; Alfaris N; Gomez G; Ricks ET; Shukla AP; Corey KE; Pratt JS; Pomp A; Rubino F; Aronne LJ
Surg Obes Relat Dis; 2017 Mar; 13(3):491-500. PubMed ID: 27986587
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Patients Older than 60.
Abbas M; Cumella L; Zhang Y; Choi J; Vemulapalli P; Melvin WS; Camacho D
Obes Surg; 2015 Dec; 25(12):2251-6. PubMed ID: 26001882
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of weight loss after gastric bypass, sleeve gastrectomy, and adjustable gastric banding.
Azagury D; Mokhtari TE; Garcia L; Rosas US; Garg T; Rivas H; Morton J
Surgery; 2019 Mar; 165(3):565-570. PubMed ID: 30316577
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence.
Murvelashvili N; Xie L; Schellinger JN; Mathew MS; Marroquin EM; Lingvay I; Messiah SE; Almandoz JP
Obesity (Silver Spring); 2023 May; 31(5):1280-1289. PubMed ID: 36998152
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Post-bariatric Abdominoplasty on Secondary Weight Regain After Roux-en-Y Gastric Bypass.
Sandvik J; Hole T; Klöckner C; Kulseng B; Wibe A
Front Endocrinol (Lausanne); 2020; 11():459. PubMed ID: 32849265
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of bariatric surgery versus liraglutide in patients with type 2 diabetes and severe obesity: a 12-month retrospective evaluation.
Cotugno M; Nosso G; Saldalamacchia G; Vitagliano G; Griffo E; Lupoli R; Angrisani L; Riccardi G; Capaldo B
Acta Diabetol; 2015 Apr; 52(2):331-6. PubMed ID: 25218924
[TBL] [Abstract][Full Text] [Related]
11. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
Peterli R; Wölnerhanssen BK; Peters T; Vetter D; Kröll D; Borbély Y; Schultes B; Beglinger C; Drewe J; Schiesser M; Nett P; Bueter M
JAMA; 2018 Jan; 319(3):255-265. PubMed ID: 29340679
[TBL] [Abstract][Full Text] [Related]
12. Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality.
Reges O; Greenland P; Dicker D; Leibowitz M; Hoshen M; Gofer I; Rasmussen-Torvik LJ; Balicer RD
JAMA; 2018 Jan; 319(3):279-290. PubMed ID: 29340677
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Liraglutide in Managing Inadequate Weight Loss and Weight Regain after Primary and Revisional Bariatric Surgery: Anthropometric and Cardiometabolic Outcomes.
Elhag W; El Ansari W
Obes Surg; 2022 Apr; 32(4):1005-1015. PubMed ID: 35060021
[TBL] [Abstract][Full Text] [Related]
14. Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery.
Trakhtenbroit MA; Leichman JG; Algahim MF; Miller CC; Moody FG; Lux TR; Taegtmeyer H
Am J Med; 2009 May; 122(5):435-42. PubMed ID: 19375553
[TBL] [Abstract][Full Text] [Related]
15. Reversal of Long-Term Weight Regain After Roux-en-Y Gastric Bypass Using Liraglutide or Surgical Revision. A Prospective Study.
Horber FF; Steffen R
Obes Surg; 2021 Jan; 31(1):93-100. PubMed ID: 32691401
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide Effects on Upper Gastrointestinal Investigations: Implications Prior to Bariatric Surgery.
Modi R; Rye P; Cawsey S; Birch DW; Sharma AM
Obes Surg; 2018 Jul; 28(7):2113-2116. PubMed ID: 29667023
[TBL] [Abstract][Full Text] [Related]
17. Is age a real or perceived discriminator for bariatric surgery? A long-term analysis of bariatric surgery in the elderly.
Prasad J; Vogels E; Dove JT; Wood C; Petrick AT; Parker DM
Surg Obes Relat Dis; 2019 May; 15(5):725-731. PubMed ID: 30737151
[TBL] [Abstract][Full Text] [Related]
18. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy.
McCloskey CA; Ramani GV; Mathier MA; Schauer PR; Eid GM; Mattar SG; Courcoulas AP; Ramanathan R
Surg Obes Relat Dis; 2007; 3(5):503-7. PubMed ID: 17903770
[TBL] [Abstract][Full Text] [Related]
19. Bariatric surgery: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(1):1-148. PubMed ID: 23074460
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Bariatric Surgery Type on Lipid Profile: An Age, Sex, Body Mass Index and Excess Weight Loss Matched Study.
Cunha FM; Oliveira J; Preto J; Saavedra A; Costa MM; Magalhães D; Lau E; Bettencourt-Silva R; Freitas P; Varela A; Carvalho D
Obes Surg; 2016 May; 26(5):1041-7. PubMed ID: 26220239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
